Anaptysbio (ANAB) FCF Margin (2016 - 2026)

Anaptysbio (ANAB) reported FCF Margin of 101.49% for Q1 2026, down 6283.0% on a YoY basis from 1.64% in Q1 2025, and down 177.67% quarter-over-quarter from 130.66% in Q4 2025.

Anaptysbio (ANAB) FCF Margin (2016 - 2026) Analysis & Trends

Anaptysbio has reported FCF Margin for 11 years, with the latest figure at 101.49% in Q1 2026.

  • For the quarter ending Q1 2026, FCF Margin fell 6283.0% year-over-year to 101.49%; the trailing twelve-month figure through Mar 2026 stood at 2.55% (up 14117.0% YoY), and the FY2025 full-year result was 8.36%, up 15702.0% from the prior year.
  • FCF Margin for Q1 2026 stood at 101.49%, down from 130.66% in the prior quarter.
  • The five-year high for FCF Margin was 130.66% in Q4 2025, with the low at 2168.35% in Q1 2022.
  • Historically, FCF Margin has averaged 650.8% across 5 years, with a median of 267.74% in 2024.
  • The largest YoY upside for FCF Margin was 228833 bps in 2022 against a maximum downside of 203879 bps in 2022.
  • Anaptysbio's FCF Margin stood at 216.22% in 2022, then tumbled by 79 bps to 387.31% in 2023, then jumped by 31 bps to 267.74% in 2024, then surged by 149 bps to 130.66% in 2025, then plunged by 178 bps to 101.49% in 2026.
  • The last three FCF Margin figures came in at 101.49% (Q1 2026), 130.66% (Q4 2025), and 54.74% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -3.98%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 43.35%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Anaptysbio 1.66 Bn 1.38 Bn - -101.49%

Historic Data

Download Data
DateValue
Mar 31, 2026 -101.49%
Dec 31, 2025 130.66%
Sep 30, 2025 -54.74%
Jun 30, 2025 -180.94%
Mar 31, 2025 -38.66%
Dec 31, 2024 -267.74%
Sep 30, 2024 -67.50%
Jun 30, 2024 -194.65%
Mar 31, 2024 -519.29%
Dec 31, 2023 -387.31%
Sep 30, 2023 -1,106.12%
Jun 30, 2023 -730.81%
Mar 31, 2023 -1,800.80%
Dec 31, 2022 -216.22%
Sep 30, 2022 -1,364.42%
Jun 30, 2022 -1,995.15%
Mar 31, 2022 -2,168.35%
Dec 31, 2021 -2,504.55%
Sep 30, 2021 -29.19%
Jun 30, 2021 43.64%